Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

3343 results about "Pcr dgge" patented technology

Denaturing gradient gel electrophoresis (DGGE) is a molecular fingerprinting method that separates polymerase chain reaction (PCR)-generated DNA products. The polymerase chain reaction of environmental DNA can generate templates of differing DNA sequence that represent many of the dominant microbial organisms.

Full-automatic nucleic acid extraction and PCR amplification micro-fluidic chip and application method thereof

The invention provides a full-automatic nucleic acid extraction and PCR amplification micro-fluidic chip which comprises at least one main body, wherein the main body is distributed in equal distance around the chip; the main body comprises a nucleic acid extraction unit, a PCR amplification unit, a waste liquid unit and an exhaust unit, wherein the nucleic acid extraction unit is positioned on the main body and is used for extracting, washing and eluting nucleic acid in sequence under the driving of centrifugal force and capillary force; the PCR amplification unit is adopted for PCR reaction amplification; the waste liquid unit comprises a waste liquid cavity which is used for storing a waste liquid; the exhaust unit comprises exhaust holes and a plurality of exhaust channels; and the plurality of exhaust channels are communicated with the nucleic acid extraction unit, the PCR amplification unit and the waste liquid unit and are used for exhausting air. The invention discloses a micro-fluidic chip for achieving full-automatic nucleic acid extraction and PCR reaction through centrifugal force, capillary force and siphon phenomenon, the micro-fluidic chip has no integrated equipment such as pumps or valves, so that the manufacturing difficulty and cost of the chip are greatly reduced, and moreover the reliability of the chip is improved.
Owner:SUZHOU INST OF BIOMEDICAL ENG & TECH CHINESE ACADEMY OF SCI

Full automatic instrument for extracting nucleic acids

The invention discloses a full automatic instrument for extracting nucleic acids, which is capable of fully automating the processes of acquiring sample information, automatically adding samples, automatically loading consumptive materials, automatically monitoring the extraction process, and establishing a PCR reaction system. The full automatic instrument for extracting nucleic acids comprises a working platform, a sample adding system which is mounted on the working platform, a deep-well multiwell plate movement device and a nucleic acid extraction device, wherein a plurality of working positions are arranged on the working platform and comprise a sample area, a reagent area and an extract product storage area. The sample adding system respectively adds the sample and a PCR reaction reagent into the deep-well multiwell plate movement device and the extract product storage area from the sample area and the reagent area respectively, the sample is moved below the nucleic acid extraction device by the deep-well multiwell plate movement device and allowed to perform the nucleic acid extraction reaction, and the extraction products are stored in the extract product storage area. The impact of human factor on experimental result can be effectively reduced, and the purity the extracted nucleic acid and the nucleic acid extraction efficiency can be improved.
Owner:苏州天隆生物科技有限公司

Fluorescence quantitative PCR detection kit of hepatitis B virus and application thereof

The invention discloses a fluorescence quantitative PCR detection kit of hepatitis B virus and an application thereof. The kit is composed of the following independent components: DNA extraction solution I, DNA extraction solution II, DNA extraction solution III, DNA extraction solution IV, positive control interior label, PCR reaction liquid, probe HBV-SP, enzyme mixed liquor containing heat resistant DNA polyase and uracil DNA glycosylase, quantitative hepatitis B virus reference material, hepatitis B virus positive control serum and hepatitis B virus negative control serum, wherein DNA extraction solution I contains 0.2-1.0% of lauryl sodium sulphate (mass/volume), 1.0-4.0% of Triton (volume/volume) and 0.2-1.0mol/L of guanidinium isothiocyanate; DNA extraction solution II contains 100-300mmol/L of 4-HEPES, 100-300mmol/L of sodium chloride with pH of 6.5+/-0.2 and 100-400 mu g/ml of magnetic beads; DNA extraction solution III contains 0.1-1.0% of Triton (volume/volume) and 100-300mmol/L of sodium chloride; DNA extraction solution IV contains mineral oil. The fluorescence quantitative PCR detection kit of hepatitis B virus of the invention can be used for detecting the HBV-DNA concentration in samples of serum, blood plasma or latex and the like.
Owner:SANSURE BIOTECH

Real-time fluorescence quantitative PCR (Polymerase Chain Reaction) kit for detecting expression level of HER2 genes

The invention provides a real-time fluorescence quantitative PCR (Polymerase Chain Reaction) kit for detecting the expression level of HER2 genes and relates to a PCR kit. The real-time fluorescence quantitative PCR kit comprises PCR reaction liquid of the HER2 genes, PCR reaction liquid of ACTB genes, a Taq enzyme system, a control product and a packaging object; and the adopted primer is an annular primer, 3-8 self-designed basic groups are at the 5' end, and can be combined with the sequence at the 3' end under proper conditions so as to form double chains. The real-time fluorescence quantitative PCR kit has the advantages that the non-specific amplification products especially primer dimer generated by nonspecific amplification products especially the primer can be effectively prevented from being formed, the specificity is increased; and a relative-quantitative RT-PCR method is utilized for detecting the expression level of the HER2 genes of a patient with the breast cancer, adopts a 2-delta deltaCt value method for quantifying the detected result, and can be used for diagnosis of early stage and transferring of the breast cancer and assisting multiple fields such as clinicalmedicine selection and prognosis.
Owner:XIAMEN UNIV

High-flux nucleic acid analysis apparatus based on microfluidic chip

The present invention discloses a high-flux nucleic acid analysis apparatus based on a microfluidic chip. The high-flux nucleic acid analysis apparatus comprises a microfluidic chip, an extraction unit, a heating unit and a detection unit. According to the present invention, under the assisting of the extraction unit, nucleic acid in a cleaved sample is captured by using the AOM membrane in the microfluidic chip, the AOM membrane is washed by using a purification and washing reagent so as to purify the nucleic acid, the nucleic acid template is retained on the AOM membrane, and the heating unit supplies stable reaction temperatures for the upper end and the lower end of a reaction chamber to make the nucleic acid template on the AOM membrane participate into a convection PCR reaction so as to achieve the integration of the nucleic acid extraction and the nucleic acid amplification; the detection unit comprises an LED lamp and a camera, wherein the LED lamp excites the fluorescent dye in the reaction reagent, and the fluorescence signals of a plurality of reaction hole positions are simultaneous detected through the camera; and the system has advantages of low complexity, simple operation and short detection time, integrates the nucleic acid extraction, the nucleic acid amplification and the nucleic acid detection, and can improve the nucleic acid diagnosis and analysis efficiency.
Owner:BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE +1

Method and device for gene sequencing of plurality of mixed DNA (Deoxyribonucleic Acid) or RNA (Ribonucleic Acid) sequences

The invention discloses a method and a device for gene sequencing of a plurality of mixed DNA (Deoxyribonucleic Acid) or RNA (Ribonucleic Acid) sequences, which is mainly characterized by adding random labels at two ends of each DNA or RNA template sequence before establishing a bank. The method comprises the following steps of: mixing a first forward primer containing the random label and a connector, a first reverse primer and the DNA sequences, performing multiple PCR (Polymerase Chain Reaction) amplification on two PCR circulations, and purifying the PCR product to obtain a first DNA product; mixing the first DNA product, a second forward primer containing a sample indexing sequence and the connector, and a second reverse primer, performing PCR reaction to obtain a second PCR product; purifying to obtain a second DNA product; and sequencing the second DNA product to obtain a sequencing result of each DNA sequence. According to the method disclosed by the invention, by introducing the random labels to each DNA molecule, the sequencing precision is improved, the error rate of the sequencing is obviously reduced, and the copy number of each DNA is precisely detected.
Owner:SOUTH UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products